Bilal Piperdi

Company: Gilead Sciences

Job title: Vice President, Clinical Development Oncology

Seminars:

Trodelvy-Immunotherapy Combinations In Solid Tumors: Rationale & Emerging Data 9:15 am

Recapping and contextualizing recent data from Phase II EVOKE-02 trial of Troveldy-Keytruda combinations in lung cancer Evaluating rationale and design of Trodelvy-immunotherapy combinations in other solid tumors Breaking down the potential – what are the route forward and potential of novel ADC-immunotherapy combinations?Read more

day: Day Two AM